The AI system offers patients personalized health management recommendations, risk monitoring, and behavioral interventions, while providing physicians with AI-powered assistants to reduce administrative tasks and boost diagnosis, treatment, and patient engagement.

As of December 31, 2025, Fangzhou serves 56.4 million registered users and 251,000 physicians, underscoring its position as a leading online chronic disease management platform in China.

The collaboration aims to deploy AI applications across diverse healthcare use cases, expanding the reach of AI-powered chronic disease services and supporting China’s healthcare digitization.

The solution, built on Fangzhou’s XingShi Large Language Model (XS LLM), targets an AI + Chronic Disease Services ecosystem under the AI + H2H model to enhance care delivery, patient outcomes, and access to professional healthcare, while reducing physicians’ administrative workload.

The initiative shifts from one-time consultations to continuous, full-cycle health management through AI integration in the AI + H2H (Hospital-to-Home) ecosystem, aiming to improve care delivery and trust between patients and providers.

The press release emphasizes a forward-looking stance centered on innovation, collaboration, and long-term health service partnership goals.

Fangzhou showcased its AI-powered Chronic Disease Services solution, developed with Tencent Health, at the 2026 Tencent Cloud AI Industry Applications Summit in Beijing.

The press release includes forward-looking statements and a caution not to overestimate their accuracy, with media contact information provided for inquiries.

Fangzhou and Tencent Health have been collaborating since November 2025, leveraging Tencent Health’s scalable computing resources, model development tools, and vector database technology to improve AI capabilities and content accuracy, enabling rapid deployment across healthcare use cases.

Fangzhou plans to expand AI-powered chronic disease services through ecosystem collaborations to drive digital transformation in China’s healthcare sector, with ongoing technological innovation and partnerships as core elements of its long-term growth strategy.